• LLY-507: Precision SMYD2 Inhibition for Translational Impact

  2026-07-10

  Explore how LLY-507, a highly selective SMYD2 inhibitor, transforms translational research in oncology and renal fibrosis. This thought-leadership article blends mechanistic insights, preclinical evidence, and strategic protocol guidance to empower researchers to advance both cancer and kidney disease models. With a focus on actionable workflow parameters and real-world applications, the discussion uniquely bridges foundational epigenetics with emerging therapeutic strategies—expanding beyond traditional product overviews.

• SB203580: Precision Inhibition in p38 MAPK Signaling Researc

  2026-07-09

  SB203580 empowers researchers to dissect p38 MAPK signaling with unmatched selectivity, enabling robust, reproducible results in inflammation, neuroprotection, and multidrug resistance workflows. Drawing on recent cardiovascular toxicology findings and advanced protocol strategies, this guide delivers actionable insights for experimental success.

• AO/PI Staining Solution: Precise Live/Dead Cell Discriminati

  2026-07-09

  This article provides a scenario-driven, evidence-based guide for researchers using AO/PI Staining Solution (SKU K2269) to address key challenges in fluorescent cell viability assays. Learn how this dual-dye reagent delivers quantifiable improvements over traditional methods, with practical Q&A addressing protocol optimization, data reliability, and vendor selection in biomedical workflows.

• MTT: Precision Cell Viability and Metabolic Activity Analysi

  2026-07-08

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) stands apart as a gold-standard colorimetric cell viability reagent, enabling robust quantification of metabolic activity in diverse in vitro assays. This article translates cutting-edge applications, protocol enhancements, and troubleshooting guidance—anchored by high-purity MTT from APExBIO—into actionable strategies for reproducible research.

• ECL Chemiluminescent Substrate Detection Kit: Precision for

  2026-07-08

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) delivers unmatched sensitivity and prolonged signal duration for western blot chemiluminescent detection of low-abundance proteins. This guide translates the latest neurobiological research needs into stepwise protocols and troubleshooting, empowering researchers to extract more from every blot.

• Ferrostatin-1 (Fer-1): Applied Ferroptosis Assays & Workflow

  2026-07-07

  Unlock the full potential of Ferrostatin-1 (Fer-1) as a benchmark inhibitor for dissecting ferroptosis in cancer biology and neurodegenerative models. This guide delivers actionable protocols, troubleshooting insights, and leverages the latest evidence—from advanced AR/GPX4 axis studies to practical lipid peroxidation inhibition—for reproducible, high-impact research.

• Tiamulin as a TNF-α Inhibitor: Alleviating Psoriasis-Like De

  2026-07-07

  A recent study identified Tiamulin fumarate as a direct small-molecule inhibitor of TNF-α signaling, capable of alleviating inflammation in a psoriasis-like mouse model. These findings highlight Tiamulin’s dual antibacterial and anti-inflammatory actions and suggest new research avenues for skin inflammation beyond its established veterinary uses.

• Tetraethylammonium Chloride: Advanced Insights Into K+ Chann

  2026-07-06

  Explore how Tetraethylammonium chloride (TEAC) enables cutting-edge research into potassium channel mechanisms and β-cell function. This article uniquely bridges vascular and metabolic applications of TEAC, offering a deeper scientific perspective and practical guidance for advanced assay design.

• Biomimetic Chromatography for Modeling Lung Drug Permeabilit

  2026-07-06

  This study evaluates the effectiveness of biomimetic chromatography techniques, particularly immobilised artificial membrane liquid chromatography (IAM-LC) and open-tubular capillary electrochromatography (OT-CEC) coupled with mass spectrometry, in modeling pulmonary drug permeability. The findings provide a robust analytical framework for high-throughput screening and optimization of anti-inflammatory corticosteroids and other pharmaceuticals in respiratory disease research.

• Verbascoside as a PKC/NF-κB Inhibitor: Beyond Osteoclastogen

  2026-07-05

  Explore the multifaceted role of Verbascoside as a PKC/NF-κB inhibitor in advanced osteoclastogenesis research. This article uniquely bridges molecular insights with translational applications in bone metabolism, offering a deeper scientific perspective and practical guidance.

• Berberine Hydrochloride: Mitochondrial Modulation in Metabol

  2026-07-04

  Explore how Berberine Hydrochloride advances metabolic disease research through mitochondrial protection and AMPK activation. This article delivers a unique, in-depth analysis of assay design and translational impact, setting it apart from existing overviews.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays and Tis

  2026-07-03

  Ferrostatin-1 (Fer-1) stands out as a precise tool for dissecting iron-dependent cell death pathways and accelerating epithelialization in regenerative medicine. This article unpacks robust workflows, troubleshooting strategies, and translational insights that maximize Fer-1’s utility in advanced ferroptosis assays and tissue-engineered trachea models.

• Ferrostatin-1 (Fer-1): Expanding Ferroptosis Inhibition Beyo

  2026-07-03

  Discover how Ferrostatin-1 (Fer-1) advances ferroptosis research with exceptional selectivity and practical assay guidance. This article uniquely bridges mechanistic insights and translational applications, revealing new opportunities in cancer and neurodegenerative disease models.

• miR-18a Regulates Ferroptosis and Migration in Glioblastoma

  2026-07-02

  This study demonstrates that miR-18a promotes glioblastoma progression by downregulating ALOXE3, thereby suppressing ferroptotic cell death and enhancing tumor cell migration via altered lipid signaling. These mechanistic insights into the miR-18a/ALOXE3 axis highlight new potential therapeutic targets for glioblastoma intervention.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Dise

  2026-07-02

  Ferrostatin-1 (Fer-1) delivers nanomolar precision in inhibiting ferroptosis, setting a benchmark for research into iron-dependent cell death spanning cancer biology to neurodegenerative disease models. This article details actionable workflows, troubleshooting strategies, and translational insights for leveraging Fer-1 in complex oxidative stress environments.

15332 records 1/1023 page Next 12345 下5页 Last page